Sam Chun Dang Pharm. Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 333.17 million compared to KRW 307.01 million a year ago.

Net income was KRW 356.36 million compared to KRW 1,838.41 million a year ago. Basic earnings per share from continuing operations was KRW 16 compared to KRW 83 a year ago. Diluted earnings per share from continuing operations was KRW 31 compared to KRW 81 a year ago.

Basic earnings per share was KRW 16 compared to KRW 83 a year ago. Diluted earnings per share was KRW 31 compared to KRW 81 a year ago.